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Abstract 
Normally, absorption of oxalate from dietary 
sources can occur in all segments of the intestinal tract. 
However, alterations in both the magnitude and direction 
of oxalate fluxes across the intestine can occur in disease 
states. In enteric hyperoxaluria, enhanced absorption of 
oxalate by the large intestine is caused by increased per-
meability of a shunt conductance induced by malabsorb-
ed bile salts and fatty acids .. In this condition, the con-
tribution of a paracellular passive flux of oxalate moving 
along its electrochemical gradient will predominate when 
intraluminal concentrations of free oxalate are high. In 
contrast, in chronic renal failure, secretion of oxalate 
can occur across both small and large intestine thereby 
facilitating extrarenal elimination with subsequent degra-
dation by mucosa) substrate-specific microorganisms. 
Clearly, in recent studies of oxalate transport, the intes-
tine has emerged with an integral role in mass balance 
of oxalate in health and disease. 
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Introduction 
The notion that intestinal transport of oxalate plays 
an important role in oxalate homeostasis is new and 
based upon recent studies demonstrating the ability of 
intestinal epithelia to regulate the magnitude and direc-
tion of oxalate transport (Hatch et al., 1984, 1993). 
Previously, the function of the intestine in oxalate handl-
ing in both health and disease was considered to be ex-
clusively absorptive (or hyperabsorptive). It is now evi-
dent that there are segmental differences in oxalate trans-
port along the length of the intestine (Hatch and Vaziri , 
1991). Thus, in addition to the established routes for 
oxalate absorption, pathways for oxalate secretion from 
blood to lumen are also present (Hatch and Vaziri, 
1991; Hatch et al., 1984, 1993). These absorptive and 
secretory pathways for transmural movements of oxalate 
across intestine can potentially contribute to oxalate 
homeostasis and to the pathogenesis of various disorders 
of oxalate metabolism. 
Epithelial Transport Mechanisms for Oxalate 
The epithelial transport mechanisms that are opera-
tive in intestinal absorption and secretion of oxalate have 
been described in some detail in the large intestine 
(Freel et al., 1980; Hatch and Vaziri, 1994a; Hatch et 
al. , 1984, 1993 , 1994a, 1994b). Furthermore, in the 
disease conditions discussed below, it is clear that the 
colon is the primary location for both the enhanced oxa-
late absorption in enteric hyperoxaluria and the secretion 
of oxalate in chronic renal failure. Alterations of small 
intestinal transport systems for oxalate have been 
suggested but not demonstrated experimentally. There 
is general consensus that the extent to which oxalate is 
absorbed by small intestinal epithelia depends upon the 
intraluminal concentration of free oxalate. The path-
ways that have been described for oxalate absorption and 
secretion across colonic epithelium are depicted in 
Figures la and lb, respectively (Hatch and Vaziri, 
1994a; Hatch et al., 1984, 1994b). Oxalate absorption 
occurs by parallel transcellular and paracellular routes . 
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Figure l. Proposed mechanisms for the transepithelial 
movements of oxalate across the mammalian distal co-
lon. Figure la depicts net oxalate absorption across the 
distal colon under normal conditions. Transcellular oxa-
late absorption occurs via active, mediated anion ex-
change systems at the apical and basolateral membranes 
of the enterocyte. A passive, paracellular flux (arrows) 
will contribute to net absorption when the 
electrochemical potential of oxalate in the lumen is 
greater than that on the blood side of the epithelium. 
Figure lb depicts active, transcellular mechanism of 
oxalate secretion. The magnitude of the net secretion of 
oxalate may be increased if the electrochemical gradient 
can support a paracellular flux of oxalate from the blood 
to lumen. Figure le depicts transmural oxalate 
movements in enteric hyperoxaluria. Despite bile salt 
and fatty acid-induced secretion of oxalate through 
transcellular pathways, the associated reduction in 
paracellular resistance results in the passive hyper-
absorption of oxalate due to higher concentrations of 
free oxalate in the lumen compared to blood. 
The electrochemical gradient of free oxalate across the 
epithelium will determine the magnitude and direction of 
passive, paracellular oxalate flux between the cells. The 
transcellular, absorptive flux of oxalate across the colon 
is an active, mediated process as judged by its sensitivity 
to metabolic and transport inhibitors (Hatch and Vaziri, 
1994a; Hatch et al., 1984, 1994b). Thus, as depicted in 
Figure la, oxalate crosses the apical membrane via a 
4-aceto-4' -isothiocyano-2,i-disulfonic stilbene (SITS)-
sensitive cr:Hco-3 exchanger (Hatch et al. , 1984, 
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1994b) and exits across the basolateral membrane by a 
4-4' -diisothiocyanostilbene-2,i-disulfonic acid (DIDS)-
sensitive anion exchanger. The latter process may be 
coupled to intracellular pH, since inhibitors of Na+ :H+ 
exchange (amiloride and its analogues) reduce oxalate 
absorption when applied serosally (Hatch et al., 1994b). 
The observed sodium dependence of oxalate absorption 
may be due to this exchange system in conjunction with 
the ouabain-sensitive basolateral Na+ :K + -ATPase. This 
basolateral exit mechanisms was also found to be sensi-
tive to the thiazide diuretics, which reduced oxalate 
absorption across colonic mucosa (Hatch and Vaziri, 
1994a). Other pathways for oxalate efflux across the 
basolateral membrane of the colonocyte may exist. 
Colonic enterocytes, presumably in the crypt region, 
also exhibit the ability to secrete oxalate when presented 
with a secretagogue. Based on inhibitor sensitivities of 
the cyclic adenosine monophosphate ( cAMP)-stimulated 
secretory process, it has been hypothesized that oxalate 
secretion occurs by mechanisms that are remarkably 
similar to that of chloride secretion (Hatch et al., 
1994b ). Thus, the colonic secretion of both chloride and, 
to a lesser degree, oxalate are reduced by mucosa! appli-
cation of the putative er-channel blocker NPPB (5-nitro-
2(3-phenylpropylamino benzoate), suggesting the possi-
bility of a common exit pathway in the apical membrane 
(Figure lb). Serosal application of furosemide, an in-
hibitor of Na+:K+ :2cr cotransport, also blocked chlo-
ride and oxalate secretion by the distal colon (Hatch et 
al. , 1994b), further suggesting a common secretory 
mechanism for the two anions. It is noteworthy that cy-
clic AMP also stimulates oxalate secretion by the rabbit 
distal ileum (Freel et al., 1995). In a preliminary re-
port, it was demonstrated that channel-like pathways for 
oxalate and chloride were present in brush border mem-
brane vesicles and it was suggested that these may repre-
sent the apical exit avenues for the anion secretion by 
this tissue (Freel et al., 1995). Note also that passive, 
paracellular fluxes of oxalate may be important depend-
ing upon the permeability of the junctional complexes 
and the magnitude and direction of the blood to lumen 
electrochemical gradient for oxalate. 
Given this brief backdrop regarding possible trans-
port avenues for oxalate in the intestine, it is possible to 
consider some clinical consequences and manifestations 
of alterations in intestinal oxalate transport in the mass 
balance of oxalate. 
Enteric Hyperoxaluria 
In enteric hyperoxaluria increased absorption of oxa-
late occurs from the lumen of the large intestine (Dob-
bins and Binder, 1976, 1977; Hofmann et al. , 1983; 
Modigliani et al., 1978). Two general mechanisms to 
explain enteric hyperoxaluria have emerged from diverse 
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studies which have addressed this issue in a variety of 
ways. One scheme describes changes in mucosa! per-
meability to oxalate resulting in increased oxalate ab-
sorption (Binder, 1974; Bright-Asare and Bincler, 1973; 
Dobbins and Binder, 1976; Earnest, 1979; Fairclough et 
al., 1977; Gaginella et al., 1976; Hatch et al., 1982, 
1983; Saunders et al., 1975) and the second scheme un-
derscores the significance of the free oxalate concentra-
tion in intraluminal contents. Since a common finding 
in individuals with enteric hyperoxaluria is the malab-
sorption of bile salts and fatty acids, many investigators 
focused on whether these agents altered mucosa! per-
meability. Using various techniques, including perfused 
colonic segments from humans (Fairclough et al., 1977) 
and both perfused loops and everted gut sac preparations 
from rats (Binder, 1974; Dobbins and Binder, 1976; 
Saunders et al., 1975), it was determined that dihydroxy 
bile salts or long chain hydroxy fatty acids increased 
oxalate absorption across the large intestine. In vitro 
experiments using isolated short-circuited sheets of colon 
from both rat (Kathpalia et al. , 1984) and rabbit (Hatch 
et al., 1982, 1983) demonstrated that bidirectional fluxes 
of oxalate increased following the addition of bile salts 
or fatty acids. For example, the addition of one to four 
mM of the dihydroxy bile salt taurochenodeoxycholate 
(TCDC) to the isolated, short-circuited mucosa of rabbit 
distal colon enhanced the paracellular, passive flux of 
oxalate and at the same time promoted a transcellular net 
secretory oxalate flux (Hatch et al., 1982, 1983). Simi-
lar effects were observed with the addition of even lower 
concentrations (0.25 to 2 mM) of the hydroxy fatty acid 
ricinoleate (Hatch et al., 1983). The relative contribu-
tion of the transcellular, active, secretory flux of oxalate 
will, however, be negligible in vivo and oxalate absorp-
tion via gradient-driven, passive diffusion through the 
paracellular pathway will likely prevail in proportion to 
luminal activity of the oxalate ion (see Figure le) . 
The importance of the luminal activity of oxalate is 
evident from numerous patient studies which have dem-
onstrated that oral administration of calcium or the resin 
cholestyramine effectively reduces hyperoxaluria by 
binding oxalate within the lumen (Earnest, et al., 1975; 
Rylander et al., 1980; Saunders et al., 1975; Smith et 
al., 1972; Stauffer et al., 1973). These conclusions 
were supported by results of in vitro experiments show-
ing that oxalate solubility was reduced in solutions in the 
presence of calcium and also in the presence of the resin 
cholestyramine (Binder, 1974; Stauffer et al., 1973). In 
addition, when oxalate solubility was determined in the 
presence of both calcium and fatty acids likely to be 
malabsorbed, it was determined that the affinity of cal-
cium for fatty acid was greater than for oxalate and the 
free concentration of oxalate was thereby increased 
(Binder, 1974; Earnest, et al., 1975). Therefore, en-
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teric hyperoxaluria can be explained by large increases 
(induced by bile salts and fatty acids) in the predomi-
nantly passive, paracellular movement of oxalate from 
lumen to blood along a concentration gradient which ul-
timately depends on its intraluminal ionic concentration. 
"Dietary" Hyperoxaluria 
Increased absorption of oxalate from the small intes-
tine leading to a hyperoxaluria that is not associated with 
malabsorption of bile salts or fatty acids is supported by 
a number of investigations (Barilla et al., 1978; Fin-
layson, 1977; Galosy et al., 1980; Hodgkinson, 1978; 
Lindsj6 et al., 1989; Marshall et al., 1972; Sigmon et 
al., 1991; Smith, 1991). The general consensus appears 
to be that increased oxalate absorption is a direct conse-
quence of oxalate bioavailability, rather than some defect 
in an oxalate transport system. It is noteworthy, how-
ever, that an increase in oxalate uptake was observed in 
intestinal rings (Farooqui et al., 1981) and isolated api-
cal membrane vesicles (Gupta et al., 1988) prepared 
from vitamin B6 deficient rats. In another study of pa-
tients with an inheritable anomaly of red blood cell oxa-
late transport, it was suggested that the erythrocyte de-
fect of enhanced uptake of oxalate might also be present 
in enterocytes (Baggio, et al., 1986; Borsatti, 1991). 
Yet , another consideration was prompted by recent in 
vitro studies identifying intestinal pathways for the se-
cretion of oxalate into the gut lumen (Hatch and Vaziri, 
1991; Hatch et al., 1993, 1994b). Using isolated short-
circuited sheets of jejunum and ileum from both rats 
(Hatch and Vaziri, 1994b) and rabbits (Hatch and 
Vaziri, 1994a), it was demonstrated that the small intes-
tine supports a basal net secretory flux of oxalate. 
These secretory pathways may be functionally more sig-
nificant in stone-formers who are presumed to hyperab-
sorb dietary oxalate. That is, reduced intestinal oxalate 
secretion alone, or possibly in conjunction with an en-
hancement of the absorptive component could explain 
absorptive or "dietary" hyperoxaluria. 
Enteric Excretion of Oxalate in 
Chronic Renal Failure 
Oxalate homeostasis may also be expected to be af-
fected by a decrease in renal function unless an extra-
renal pathway for oxalate excretion compensates for re-
duced renal elimination. Two recent studies have pro-
vided evidence suggesting that enteric excretion of oxa-
late in rats with chronic renal failure (CRF) (Costello, 
et al., 1992; Hatch et al., 1994a) may contribute to oxa-
late homeostasis in this model. In one whole animal 
study, the fate of 14C-oxalate infused by a mini osmotic 
pump in normal rats and rats with experimentally in-
duced chronic renal failure, was determined over several 
days (Costello et al., 1992). It was observed that fecal 
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excretion of the tracer was significantly higher in CRF 
rats when compared to normals, suggesting that excre-
tion of oxalate by the intestinal route is important in 
renal failure. In a separate study, a direct examination 
of oxalate fluxes across isolated, short-circuited intestinal 
segments removed from a similar rat model demonstrat-
ed that colonic transport of oxalate is markedly changed 
(Hatch et al., 1994a). It was shown that basal oxalate 
absorption observed in the colon of control rats was 
changed to net oxalate secretion in CRF rats 6 weeks 
following 5/6 nephrectomy. The reversal in the direc-
tion of net oxalate transport under short-circuit condi-
tions was due to an increase in the transcellular serosal 
to mucosal flux of oxalate across the colon. The basal 
secretory flux of oxalate across the jejunum and ileum, 
however, was not altered in this model of renal insuffi-
ciency. We now assume that CRF associated oxalate se-
cretion by the rat colon observed in vitro is mechanistic-
ally similar to cAMP-dependent oxalate secretion previ-
ously described for the rabbit colon (Figure lb). While 
significant changes in paracellular conductance were not 
evident in the in vitro rat model (Hatch et al., 1994a), 
enteric elimination through this shunt may also be signif-
icant in vivo, given the concomitant changes in trans-
epithelial oxalate gradient in CRF as considered below. 
Several pieces of information suggest that in patients 
with oxalosis or renal failure, a chemical gradient favor-
ing passive, paracellular oxalate secretion across the in-
testine may exist at times. First, it has been shown that 
these patients have serum oxalate levels up to 50-fold 
higher (0.1 mM) than healthy individuals (Kasidas et al., 
1990). Second, in a pilot study in our laboratory, we 
observed that intraluminal concentrations of oxalate are 
relatively low (micromolar range) . Oxalate was deter-
mined, by a double enzymatic method (Hatch, 1990), in 
acidified specimens of intestinal fluid obtained from 
eight surgical patients who were being fed parenterally 
for at least ten days. Samples of gastric juice obtained 
from five of the individuals yielded concentrations of 
oxalate ranging from 3.6 to 79 µM with a mean and 
standard deviation of 23.3 ± 16 µM . In two individ-
uals, oxalate concentrations in fluid removed from the 
small intestine were 37.7 and 51.1 µM, and in another 
individual, oxalate concentration in a colonic fluid speci-
men was found to be 41.7 µM. These initial estimates 
of intraluminal oxalate concentrations are most likely 
representative of concentrations that would be found un-
der fasting conditions and post-prandial concentrations of 
oxalate will depend upon the dietary oxalate load in 
healthy individuals ingesting a normal diet. Neverthe-
less, in these patients, it would appear that the concen-
tration gradients across enteric epithelia would favor the 
passive, paracellular elimination. Finally, the observa-
tion that an increased population of oxalate-degrading 
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microorganisms was found in the large intestine of pa-
tients with CRF (Comici et al., 1982), suggests a meta-
bolic sump for maintaining the transcolonic gradient for 
the passive oxalate movement into the lumen. These 
passive avenues, coupled with active colonic secretion of 
oxalate, may then represent an important extrarenal 
pathway for oxalate elimination in chronic renal failure. 
Summary 
There is no substantive evidence regarding an altera-
tion or defect in small intestinal epithelial transport sys-
tems for oxalate which would result in oxalate hyper-
absorption. There is general agreement, however, that 
increased oxalate absorption from the small intestine de-
pends upon an increase in luminal oxalate bioavailabili-
ty. In "leaky" epithelia, such as the small intestine, the 
contribution of the paracellular passive flux of oxalate 
will predominate when intraluminal oxalate concentra-
tions are high resulting in oxalate absorption in vivo. 
Recent studies, demonstrating that the jejunum and ileum 
can actively secrete oxalate, suggest that transcellular 
secretory pathways may be functionally important in 
both health and disease. The potential contribution of 
these physiologically relevant secretory pathways in dis-
ease states requires consideration. 
In contrast, more information is available regarding 
the involvement of large intestinal oxalate transport in 
the context of disease states. In enteric hyperoxaluria, 
the colon is the site of increased oxalate absorption as a 
consequence of increased epithelial permeability and in-
creased concentrations of free oxalate within the lumen. 
In chronic renal failure associated hyperoxalemia, basal 
colonic absorption of oxalate is reversed to a secretory 
flux resulting in extrarenal excretion of oxalate. 
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Discussion With Reviewers 
V.R. Franceschi: The possibility is raised that a com-
mon exit pathway may exist in the apical membrane for 
chloride and oxalate ions. Have experiments been per-
formed to look for competitive inhibition of transport of 
one ion by the other in the various systems upon which 
that hypothesis is based? 
Authors: It is not possible to perform such experiments 
using whole tissues where the apical and basolateral 
membrane barriers are located in series with one an-
other. While apical membrane vesicle preparations are 
more appropriate for such competition studies, we have 
not yet performed these kinds of experiments since they 
are difficult to interpret unless we know, a priori, that 
a single conductive pathway mediates the voltage-de-
pendent accumulation of both anions. For example, an 
apparent cis-inhibition of oxalate uptake by chloride 
could be due to competition if a single pathway mediated 
their flux. However, separate pathways would produce 
a similar experimental result (apparent cis-inhibition) 
because chloride uptake via its pathway would short-cir-
cuit the imposed voltage (driving force) and thereby 
depress oxalate uptake via its pathway. 
R.P. Holmes: Is the main purpose of the er (oxa-
late):HC0-3 exchanger to prevent over-acidification of 
luminal contents? Similarly, in the reverse direction, is 
the secretion of er and oxalate to ensure that there is 
sufficient counter-ion for HC0-3 secretion? 
Authors: The cr:HC0-3 exchanger located on the api-
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cal membrane of the enterocyte is one of the membrane 
transport systems involved in the regulation of intracel-
lular pH. The membrane pathways involved in er se-
cretion, i.e., basolateral Na+:K+:zcr in series with an 
apical conductive pathway, may be indirectly coupled to 
intracellular pH regulatory transport mechanisms. 
R.P. Holmes: Does acetate, the major anion in colonic 
fluid, compete with oxalate for active absorption? 
Authors: We have demonstrated that the isolated, 
short-circuited rabbit colon supports a ·net absorptive 
flux of oxalate, however, this tissue does not support net 
acetate absorption under similar conditions (Hatch, 
1987). A small, but insignificant net secretion of acetate 
was observed across the colon. Hence, it is difficult to 
conclude that acetate competes with oxalate for the 
membrane transport systems involved in the absorption 
of both organic anions. The observed secretion of ace-
tate may reflect the existence of an anion secretory 
mechanism that can accommodate short chain fatty acids 
in an in vitro system. Studies using brush border mem-
brane vesicles from rat colon suggest that oxalate is a 
poor substrate for the short chain fatty acid exchanger 
(Mascola et al., 1991). The fact that, in vivo, the large 
intestine can absorb large quantities of SCF As under-
scores important physio-chemical differences between in 
vivo conditions and the symmetrical electrochemical en-
vironment of the Ussing chamber. 
R.P. Holmes: Can an osmotic gradient in the colon 
contribute as a driving force for paracellular transport? 
Authors: Yes, a hyperosmotic gradient can contribute 
to the driving force for paracellular transport of solutes. 
For example, lurninal hypertonicity could support a 
serosal to mucosa! flux of any solute entrained in the 
bulk flow of solution if no steric or electrostatic 
restrictions were imposed by the diffusion pathway. 
R.P. Holmes: Could electroneutral complexes of 
calcium oxalate and magnesium oxalate be absorbed 
through the paracellular pathway? 
Authors: Theoretically, this is a possible mode of 
transport that would be limited primarily by the size of 
the complex and the resistance of the paracellular path-
way. There is no experimental evidence to either support 
or negate such a mode of transepithelial transport. 
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